BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31646814)

  • 1. Correlations of gastrointestinal hormones with inflammation and intestinal flora in patients with gastric cancer.
    Zhou G; Yang J
    J BUON; 2019; 24(4):1595-1600. PubMed ID: 31646814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of recurrence of gastric cancer in patients after radical surgery with serum gastrointestinal hormones, vascular endothelial growth factors and serum anti-helicobacter pylori IgG antibody.
    Feng X; Shi XMY
    J BUON; 2020; 25(3):1476-1481. PubMed ID: 32862593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
    So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
    Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
    Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
    World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic and serum risk markers for noncardia early gastric cancer.
    Shiotani A; Iishi H; Uedo N; Kumamoto M; Nakae Y; Ishiguro S; Tatsuta M; Graham DY
    Int J Cancer; 2005 Jun; 115(3):463-9. PubMed ID: 15688378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
    Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
    Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M; Peczek Ł; Rudnicki C; Nawrot B; Stec-Michalska K
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative.
    Jonkers D; Houben P; Hameeteman W; Stobberingh E; de Bruine A; Arends JW; Biemond I; Lundqvist G; Stockbrügger R
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(9):836-41. PubMed ID: 10669990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gastrin-17 and its related influencing factors in physical examination results.
    Zeng J; Shen Y; Xu S; Yang R
    Immun Inflamm Dis; 2023 Oct; 11(10):e993. PubMed ID: 37904688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new modified ABCD method for gastric neoplasm screening.
    Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
    Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
    Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
    Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais.
    Yamada S; Matsuhisa T; Makonkawkeyoon L; Chaidatch S; Kato S; Matsukura N
    J Gastroenterol; 2006 Dec; 41(12):1169-77. PubMed ID: 17287896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
    Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.